Xencor (XNCR) Revenue (QoQ) (2013 - 2026)
Xencor (XNCR) Revenue (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - |
| 10 | Xencor | 1.48 Bn | 1.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.01% |
| Dec 31, 2025 | 34.47% |
| Sep 30, 2025 | -51.85% |
| Jun 30, 2025 | 33.23% |
| Mar 31, 2025 | -38.00% |
| Dec 31, 2024 | 196.66% |
| Sep 30, 2024 | -25.56% |
| Jun 30, 2024 | 49.45% |
| Mar 31, 2024 | -68.64% |
| Dec 31, 2023 | -13.83% |
| Sep 30, 2023 | 30.11% |
| Jun 30, 2023 | 139.47% |
| Mar 31, 2023 | -12.08% |
| Dec 31, 2022 | -20.84% |
| Sep 30, 2022 | -9.61% |
| Jun 30, 2022 | -64.68% |
| Mar 31, 2022 | -44.49% |
| Dec 31, 2021 | 682.46% |
| Sep 30, 2021 | -70.82% |
| Jun 30, 2021 | 98.37% |